nodes	percent_of_prediction	percent_of_DWPC	metapath
Efavirenz—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.121	0.201	CbGbCtD
Efavirenz—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0763	0.126	CbGbCtD
Efavirenz—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0639	0.106	CbGbCtD
Efavirenz—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.061	0.101	CbGbCtD
Efavirenz—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.0518	0.0859	CbGbCtD
Efavirenz—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.04	0.0663	CbGbCtD
Efavirenz—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0372	0.0616	CbGbCtD
Efavirenz—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.0347	0.0576	CbGbCtD
Efavirenz—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0298	0.0495	CbGbCtD
Efavirenz—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0274	0.0454	CbGbCtD
Efavirenz—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0171	0.0283	CbGbCtD
Efavirenz—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0168	0.0278	CbGbCtD
Efavirenz—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0156	0.0259	CbGbCtD
Efavirenz—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0107	0.0177	CbGbCtD
Efavirenz—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000153	0.000385	CcSEcCtD
Efavirenz—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000153	0.000384	CcSEcCtD
Efavirenz—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000384	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000152	0.000384	CcSEcCtD
Efavirenz—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000381	CcSEcCtD
Efavirenz—Pain—Cisplatin—peripheral nervous system neoplasm	0.000151	0.00038	CcSEcCtD
Efavirenz—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000379	CcSEcCtD
Efavirenz—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000149	0.000374	CcSEcCtD
Efavirenz—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000374	CcSEcCtD
Efavirenz—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000373	CcSEcCtD
Efavirenz—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000371	CcSEcCtD
Efavirenz—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000147	0.00037	CcSEcCtD
Efavirenz—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000146	0.000369	CcSEcCtD
Efavirenz—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000366	CcSEcCtD
Efavirenz—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000145	0.000366	CcSEcCtD
Efavirenz—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000145	0.000366	CcSEcCtD
Efavirenz—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000364	CcSEcCtD
Efavirenz—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000144	0.000363	CcSEcCtD
Efavirenz—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000362	CcSEcCtD
Efavirenz—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000144	0.000362	CcSEcCtD
Efavirenz—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000143	0.000361	CcSEcCtD
Efavirenz—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000143	0.00036	CcSEcCtD
Efavirenz—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000358	CcSEcCtD
Efavirenz—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000358	CcSEcCtD
Efavirenz—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000358	CcSEcCtD
Efavirenz—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000142	0.000358	CcSEcCtD
Efavirenz—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000142	0.000357	CcSEcCtD
Efavirenz—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000355	CcSEcCtD
Efavirenz—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000141	0.000355	CcSEcCtD
Efavirenz—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00014	0.000354	CcSEcCtD
Efavirenz—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000353	CcSEcCtD
Efavirenz—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000352	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000139	0.000352	CcSEcCtD
Efavirenz—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000139	0.000351	CcSEcCtD
Efavirenz—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000139	0.000351	CcSEcCtD
Efavirenz—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000351	CcSEcCtD
Efavirenz—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000349	CcSEcCtD
Efavirenz—Pain—Etoposide—peripheral nervous system neoplasm	0.000138	0.000348	CcSEcCtD
Efavirenz—Constipation—Etoposide—peripheral nervous system neoplasm	0.000138	0.000348	CcSEcCtD
Efavirenz—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000345	CcSEcCtD
Efavirenz—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000137	0.000345	CcSEcCtD
Efavirenz—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000136	0.000344	CcSEcCtD
Efavirenz—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000343	CcSEcCtD
Efavirenz—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000341	CcSEcCtD
Efavirenz—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000339	CcSEcCtD
Efavirenz—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000339	CcSEcCtD
Efavirenz—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000336	CcSEcCtD
Efavirenz—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000133	0.000336	CcSEcCtD
Efavirenz—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000335	CcSEcCtD
Efavirenz—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000133	0.000334	CcSEcCtD
Efavirenz—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000333	CcSEcCtD
Efavirenz—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000132	0.000333	CcSEcCtD
Efavirenz—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000132	0.000332	CcSEcCtD
Efavirenz—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000132	0.000332	CcSEcCtD
Efavirenz—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000331	CcSEcCtD
Efavirenz—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000331	CcSEcCtD
Efavirenz—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000331	CcSEcCtD
Efavirenz—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000131	0.000329	CcSEcCtD
Efavirenz—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00013	0.000329	CcSEcCtD
Efavirenz—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000328	CcSEcCtD
Efavirenz—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00013	0.000328	CcSEcCtD
Efavirenz—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00013	0.000327	CcSEcCtD
Efavirenz—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000326	CcSEcCtD
Efavirenz—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000325	CcSEcCtD
Efavirenz—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000128	0.000324	CcSEcCtD
Efavirenz—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000323	CcSEcCtD
Efavirenz—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000322	CcSEcCtD
Efavirenz—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000128	0.000322	CcSEcCtD
Efavirenz—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000128	0.000322	CcSEcCtD
Efavirenz—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000321	CcSEcCtD
Efavirenz—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000127	0.00032	CcSEcCtD
Efavirenz—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000127	0.00032	CcSEcCtD
Efavirenz—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000127	0.000319	CcSEcCtD
Efavirenz—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000318	CcSEcCtD
Efavirenz—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000317	CcSEcCtD
Efavirenz—Rash—Vincristine—peripheral nervous system neoplasm	0.000126	0.000317	CcSEcCtD
Efavirenz—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000126	0.000317	CcSEcCtD
Efavirenz—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000317	CcSEcCtD
Efavirenz—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000316	CcSEcCtD
Efavirenz—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000316	CcSEcCtD
Efavirenz—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000315	CcSEcCtD
Efavirenz—Headache—Vincristine—peripheral nervous system neoplasm	0.000125	0.000315	CcSEcCtD
Efavirenz—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000313	CcSEcCtD
Efavirenz—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000311	CcSEcCtD
Efavirenz—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000123	0.00031	CcSEcCtD
Efavirenz—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000123	0.00031	CcSEcCtD
Efavirenz—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000121	0.000304	CcSEcCtD
Efavirenz—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000304	CcSEcCtD
Efavirenz—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000119	0.0003	CcSEcCtD
Efavirenz—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000119	0.0003	CcSEcCtD
Efavirenz—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000119	0.0003	CcSEcCtD
Efavirenz—Nausea—Vincristine—peripheral nervous system neoplasm	0.000118	0.000299	CcSEcCtD
Efavirenz—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000298	CcSEcCtD
Efavirenz—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000298	CcSEcCtD
Efavirenz—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000298	CcSEcCtD
Efavirenz—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000297	CcSEcCtD
Efavirenz—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000296	CcSEcCtD
Efavirenz—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000294	CcSEcCtD
Efavirenz—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000293	CcSEcCtD
Efavirenz—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000116	0.000292	CcSEcCtD
Efavirenz—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000292	CcSEcCtD
Efavirenz—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000292	CcSEcCtD
Efavirenz—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000291	CcSEcCtD
Efavirenz—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000115	0.00029	CcSEcCtD
Efavirenz—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000115	0.00029	CcSEcCtD
Efavirenz—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000114	0.000288	CcSEcCtD
Efavirenz—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000287	CcSEcCtD
Efavirenz—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000287	CcSEcCtD
Efavirenz—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000284	CcSEcCtD
Efavirenz—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000112	0.000283	CcSEcCtD
Efavirenz—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000281	CcSEcCtD
Efavirenz—Rash—Cisplatin—peripheral nervous system neoplasm	0.000111	0.00028	CcSEcCtD
Efavirenz—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000111	0.00028	CcSEcCtD
Efavirenz—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000111	0.00028	CcSEcCtD
Efavirenz—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000111	0.00028	CcSEcCtD
Efavirenz—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000111	0.000279	CcSEcCtD
Efavirenz—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000278	CcSEcCtD
Efavirenz—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000277	CcSEcCtD
Efavirenz—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000276	CcSEcCtD
Efavirenz—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000276	CcSEcCtD
Efavirenz—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000276	CcSEcCtD
Efavirenz—Tension—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000274	CcSEcCtD
Efavirenz—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000274	CcSEcCtD
Efavirenz—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000272	CcSEcCtD
Efavirenz—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000271	CcSEcCtD
Efavirenz—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.00027	CcSEcCtD
Efavirenz—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000107	0.000269	CcSEcCtD
Efavirenz—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000269	CcSEcCtD
Efavirenz—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000268	CcSEcCtD
Efavirenz—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000266	CcSEcCtD
Efavirenz—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000105	0.000264	CcSEcCtD
Efavirenz—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000264	CcSEcCtD
Efavirenz—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000263	CcSEcCtD
Efavirenz—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000103	0.00026	CcSEcCtD
Efavirenz—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000103	0.000259	CcSEcCtD
Efavirenz—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000259	CcSEcCtD
Efavirenz—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000259	CcSEcCtD
Efavirenz—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000259	CcSEcCtD
Efavirenz—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000257	CcSEcCtD
Efavirenz—Rash—Etoposide—peripheral nervous system neoplasm	0.000102	0.000257	CcSEcCtD
Efavirenz—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000102	0.000257	CcSEcCtD
Efavirenz—Headache—Etoposide—peripheral nervous system neoplasm	0.000101	0.000255	CcSEcCtD
Efavirenz—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000255	CcSEcCtD
Efavirenz—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000254	CcSEcCtD
Efavirenz—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000253	CcSEcCtD
Efavirenz—Malaise—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000252	CcSEcCtD
Efavirenz—Nervousness—Doxorubicin—peripheral nervous system neoplasm	9.97e-05	0.000251	CcSEcCtD
Efavirenz—Vertigo—Epirubicin—peripheral nervous system neoplasm	9.97e-05	0.000251	CcSEcCtD
Efavirenz—Syncope—Epirubicin—peripheral nervous system neoplasm	9.95e-05	0.000251	CcSEcCtD
Efavirenz—Back pain—Doxorubicin—peripheral nervous system neoplasm	9.93e-05	0.00025	CcSEcCtD
Efavirenz—Palpitations—Epirubicin—peripheral nervous system neoplasm	9.81e-05	0.000247	CcSEcCtD
Efavirenz—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	9.75e-05	0.000246	CcSEcCtD
Efavirenz—Cough—Epirubicin—peripheral nervous system neoplasm	9.68e-05	0.000244	CcSEcCtD
Efavirenz—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	9.68e-05	0.000244	CcSEcCtD
Efavirenz—Convulsion—Epirubicin—peripheral nervous system neoplasm	9.62e-05	0.000242	CcSEcCtD
Efavirenz—Nausea—Etoposide—peripheral nervous system neoplasm	9.6e-05	0.000242	CcSEcCtD
Efavirenz—Hypertension—Epirubicin—peripheral nervous system neoplasm	9.58e-05	0.000242	CcSEcCtD
Efavirenz—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	9.53e-05	0.00024	CcSEcCtD
Efavirenz—Anaemia—Doxorubicin—peripheral nervous system neoplasm	9.49e-05	0.000239	CcSEcCtD
Efavirenz—Arthralgia—Epirubicin—peripheral nervous system neoplasm	9.45e-05	0.000238	CcSEcCtD
Efavirenz—Myalgia—Epirubicin—peripheral nervous system neoplasm	9.45e-05	0.000238	CcSEcCtD
Efavirenz—Chest pain—Epirubicin—peripheral nervous system neoplasm	9.45e-05	0.000238	CcSEcCtD
Efavirenz—Agitation—Doxorubicin—peripheral nervous system neoplasm	9.44e-05	0.000238	CcSEcCtD
Efavirenz—Anxiety—Epirubicin—peripheral nervous system neoplasm	9.42e-05	0.000237	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	9.38e-05	0.000237	CcSEcCtD
Efavirenz—Discomfort—Epirubicin—peripheral nervous system neoplasm	9.33e-05	0.000235	CcSEcCtD
Efavirenz—Malaise—Doxorubicin—peripheral nervous system neoplasm	9.26e-05	0.000233	CcSEcCtD
Efavirenz—Dry mouth—Epirubicin—peripheral nervous system neoplasm	9.24e-05	0.000233	CcSEcCtD
Efavirenz—Vertigo—Doxorubicin—peripheral nervous system neoplasm	9.23e-05	0.000233	CcSEcCtD
Efavirenz—Syncope—Doxorubicin—peripheral nervous system neoplasm	9.21e-05	0.000232	CcSEcCtD
Efavirenz—Confusional state—Epirubicin—peripheral nervous system neoplasm	9.13e-05	0.00023	CcSEcCtD
Efavirenz—Palpitations—Doxorubicin—peripheral nervous system neoplasm	9.07e-05	0.000229	CcSEcCtD
Efavirenz—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	9.03e-05	0.000227	CcSEcCtD
Efavirenz—Cough—Doxorubicin—peripheral nervous system neoplasm	8.96e-05	0.000226	CcSEcCtD
Efavirenz—Shock—Epirubicin—peripheral nervous system neoplasm	8.91e-05	0.000225	CcSEcCtD
Efavirenz—Convulsion—Doxorubicin—peripheral nervous system neoplasm	8.9e-05	0.000224	CcSEcCtD
Efavirenz—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	8.88e-05	0.000224	CcSEcCtD
Efavirenz—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	8.87e-05	0.000224	CcSEcCtD
Efavirenz—Hypertension—Doxorubicin—peripheral nervous system neoplasm	8.87e-05	0.000223	CcSEcCtD
Efavirenz—Tachycardia—Epirubicin—peripheral nervous system neoplasm	8.84e-05	0.000223	CcSEcCtD
Efavirenz—Skin disorder—Epirubicin—peripheral nervous system neoplasm	8.8e-05	0.000222	CcSEcCtD
Efavirenz—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	8.76e-05	0.000221	CcSEcCtD
Efavirenz—Chest pain—Doxorubicin—peripheral nervous system neoplasm	8.74e-05	0.00022	CcSEcCtD
Efavirenz—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	8.74e-05	0.00022	CcSEcCtD
Efavirenz—Myalgia—Doxorubicin—peripheral nervous system neoplasm	8.74e-05	0.00022	CcSEcCtD
Efavirenz—Anxiety—Doxorubicin—peripheral nervous system neoplasm	8.71e-05	0.00022	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	8.68e-05	0.000219	CcSEcCtD
Efavirenz—Discomfort—Doxorubicin—peripheral nervous system neoplasm	8.64e-05	0.000218	CcSEcCtD
Efavirenz—Anorexia—Epirubicin—peripheral nervous system neoplasm	8.63e-05	0.000218	CcSEcCtD
Efavirenz—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	8.55e-05	0.000216	CcSEcCtD
Efavirenz—Confusional state—Doxorubicin—peripheral nervous system neoplasm	8.45e-05	0.000213	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	8.25e-05	0.000208	CcSEcCtD
Efavirenz—Shock—Doxorubicin—peripheral nervous system neoplasm	8.24e-05	0.000208	CcSEcCtD
Efavirenz—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	8.22e-05	0.000207	CcSEcCtD
Efavirenz—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	8.21e-05	0.000207	CcSEcCtD
Efavirenz—Insomnia—Epirubicin—peripheral nervous system neoplasm	8.19e-05	0.000206	CcSEcCtD
Efavirenz—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	8.18e-05	0.000206	CcSEcCtD
Efavirenz—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	8.14e-05	0.000205	CcSEcCtD
Efavirenz—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	8.13e-05	0.000205	CcSEcCtD
Efavirenz—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	8.1e-05	0.000204	CcSEcCtD
Efavirenz—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	8.07e-05	0.000204	CcSEcCtD
Efavirenz—Somnolence—Epirubicin—peripheral nervous system neoplasm	8.05e-05	0.000203	CcSEcCtD
Efavirenz—Anorexia—Doxorubicin—peripheral nervous system neoplasm	7.99e-05	0.000201	CcSEcCtD
Efavirenz—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	7.97e-05	0.000201	CcSEcCtD
Efavirenz—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	7.87e-05	0.000198	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	7.82e-05	0.000197	CcSEcCtD
Efavirenz—Fatigue—Epirubicin—peripheral nervous system neoplasm	7.81e-05	0.000197	CcSEcCtD
Efavirenz—Pain—Epirubicin—peripheral nervous system neoplasm	7.75e-05	0.000195	CcSEcCtD
Efavirenz—Constipation—Epirubicin—peripheral nervous system neoplasm	7.75e-05	0.000195	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	7.64e-05	0.000192	CcSEcCtD
Efavirenz—Insomnia—Doxorubicin—peripheral nervous system neoplasm	7.58e-05	0.000191	CcSEcCtD
Efavirenz—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	7.53e-05	0.00019	CcSEcCtD
Efavirenz—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	7.47e-05	0.000188	CcSEcCtD
Efavirenz—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	7.46e-05	0.000188	CcSEcCtD
Efavirenz—Somnolence—Doxorubicin—peripheral nervous system neoplasm	7.45e-05	0.000188	CcSEcCtD
Efavirenz—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	7.41e-05	0.000187	CcSEcCtD
Efavirenz—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	7.38e-05	0.000186	CcSEcCtD
Efavirenz—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	7.29e-05	0.000184	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	7.24e-05	0.000182	CcSEcCtD
Efavirenz—Fatigue—Doxorubicin—peripheral nervous system neoplasm	7.23e-05	0.000182	CcSEcCtD
Efavirenz—Urticaria—Epirubicin—peripheral nervous system neoplasm	7.2e-05	0.000181	CcSEcCtD
Efavirenz—Pain—Doxorubicin—peripheral nervous system neoplasm	7.17e-05	0.000181	CcSEcCtD
Efavirenz—Constipation—Doxorubicin—peripheral nervous system neoplasm	7.17e-05	0.000181	CcSEcCtD
Efavirenz—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	7.16e-05	0.00018	CcSEcCtD
Efavirenz—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	7.16e-05	0.00018	CcSEcCtD
Efavirenz—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	6.91e-05	0.000174	CcSEcCtD
Efavirenz—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	6.85e-05	0.000173	CcSEcCtD
Efavirenz—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	6.67e-05	0.000168	CcSEcCtD
Efavirenz—Urticaria—Doxorubicin—peripheral nervous system neoplasm	6.66e-05	0.000168	CcSEcCtD
Efavirenz—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	6.62e-05	0.000167	CcSEcCtD
Efavirenz—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	6.62e-05	0.000167	CcSEcCtD
Efavirenz—Asthenia—Epirubicin—peripheral nervous system neoplasm	6.5e-05	0.000164	CcSEcCtD
Efavirenz—Pruritus—Epirubicin—peripheral nervous system neoplasm	6.41e-05	0.000162	CcSEcCtD
Efavirenz—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	6.2e-05	0.000156	CcSEcCtD
Efavirenz—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	6.17e-05	0.000156	CcSEcCtD
Efavirenz—Asthenia—Doxorubicin—peripheral nervous system neoplasm	6.01e-05	0.000152	CcSEcCtD
Efavirenz—Dizziness—Epirubicin—peripheral nervous system neoplasm	5.99e-05	0.000151	CcSEcCtD
Efavirenz—Pruritus—Doxorubicin—peripheral nervous system neoplasm	5.93e-05	0.000149	CcSEcCtD
Efavirenz—Vomiting—Epirubicin—peripheral nervous system neoplasm	5.76e-05	0.000145	CcSEcCtD
Efavirenz—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	5.73e-05	0.000145	CcSEcCtD
Efavirenz—Rash—Epirubicin—peripheral nervous system neoplasm	5.71e-05	0.000144	CcSEcCtD
Efavirenz—Dermatitis—Epirubicin—peripheral nervous system neoplasm	5.71e-05	0.000144	CcSEcCtD
Efavirenz—Headache—Epirubicin—peripheral nervous system neoplasm	5.67e-05	0.000143	CcSEcCtD
Efavirenz—Dizziness—Doxorubicin—peripheral nervous system neoplasm	5.54e-05	0.00014	CcSEcCtD
Efavirenz—Nausea—Epirubicin—peripheral nervous system neoplasm	5.38e-05	0.000136	CcSEcCtD
Efavirenz—Vomiting—Doxorubicin—peripheral nervous system neoplasm	5.33e-05	0.000134	CcSEcCtD
Efavirenz—Rash—Doxorubicin—peripheral nervous system neoplasm	5.28e-05	0.000133	CcSEcCtD
Efavirenz—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	5.28e-05	0.000133	CcSEcCtD
Efavirenz—Headache—Doxorubicin—peripheral nervous system neoplasm	5.25e-05	0.000132	CcSEcCtD
Efavirenz—Nausea—Doxorubicin—peripheral nervous system neoplasm	4.98e-05	0.000125	CcSEcCtD
